| 2023-01-17 15:42 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.24 | News Release200 | Aeterna hopes for Detect trial OK in H1 |
| 2022-12-02 08:29 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.18 | In the News525 | Globe says Buhler, others good for bargain hunters |
| 2022-11-03 11:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.58 | News Release200 | Aeterna loses $3.4-million (U.S.) in Q3 2022 |
| 2022-11-03 08:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.58 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2022-11-03 08:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 5.58 | SEDAR MD & A815 | SEDAR MD & A |
| 2022-08-29 09:31 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.63 | News Release200 | Aeterna to regain full rights to macimorelin from Novo |
| 2022-08-03 19:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.335 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2022-08-03 19:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.335 | SEDAR MD & A815 | SEDAR MD & A |
| 2022-08-03 18:59 | CC:AEZS | Aeterna Zentaris Inc (4) | 6.335 | News Release200 | Aeterna loses $4.2-million (U.S.) in Q2 |
| 2022-07-19 20:10 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.265 | Rollback291 | Aeterna Zentaris 1:25 share rollback |
| 2022-07-18 17:14 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.28 | News Release200 | Aeterna's 1:25 share rollback to take effect July 21 |
| 2022-07-15 16:29 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.295 | News Release200 | Aeterna receives shareholder OK for 1:25 share rollback |
| 2022-07-06 16:49 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.26 | News Release200 | Aeterna further adjourns meeting, hopes for rollback OK |
| 2022-06-21 16:58 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.23 | News Release200 | Aeterna Zentaris adjourns meeting to seek rollback OK |
| 2022-06-13 12:14 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.25 | News Release200 | Aeterna reaches proof of concept for NMOSD program |
| 2022-05-25 16:41 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.26 | News Release200 | Aeterna partner Consilient releases Ghryvelin in Europe |
| 2022-05-16 13:11 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.25 | News Release200 | Aeterna to hold AGM June 21, proposes share rollback |
| 2022-05-11 12:48 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.295 | News Release200 | Aeterna losses rise to $2.6-million (U.S.) in Q1 2022 |
| 2022-05-10 21:26 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.295 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2022-05-10 21:26 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.295 | SEDAR MD & A815 | SEDAR MD & A |
| 2022-04-19 12:43 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.41 | News Release200 | Aeterna receives European patent for macimorelin |
| 2022-03-29 11:44 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.455 | News Release200 | Aeterna Zentaris loses $8.4-million in 2021 |
| 2022-03-28 22:45 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.465 | SEDAR MD & A815 | SEDAR MD & A |
| 2022-03-28 22:44 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.465 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2022-03-28 22:36 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.465 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2022-03-21 11:55 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.435 | News Release200 | Aeterna halts Detect study enrolment in Ukraine, Russia |
| 2022-03-10 12:07 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.44 | News Release200 | Aeterna Zentaris increases scope of vaccine studies |
| 2022-03-02 11:54 | CC:AEZS | Aeterna Zentaris Inc (3) | 0.44 | News Release200 | Aeterna Zentaris licensor receives patent allowance |